EVOLUS, INC. Payments for Software
EVOLUS, INC. (EOLS) reported Payments for Software of $1.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForSoftware · last filed 2026-08-05
- EVOLUS, INC. payments for software for the quarter ending 2026-06-30 was $450.00K, a 71.50% decline year-over-year.
- EVOLUS, INC. payments for software for the quarter ending 2026-03-31 was $1.28M, a 17.25% decline year-over-year.
- EVOLUS, INC. payments for software for the quarter ending 2025-12-31 was $687.00K, a 25.65% decline year-over-year.
- EVOLUS, INC. payments for software for the quarter ending 2025-09-30 was $1.20M, a 9.66% increase year-over-year.
- EVOLUS, INC. payments for software for fiscal 2025 was $5.01M, a 49.54% increase from fiscal 2024.
- EVOLUS, INC. payments for software for fiscal 2024 was $3.35M, a 190.38% increase from fiscal 2023.
- EVOLUS, INC. payments for software for fiscal 2023 was $1.15M, a 12.64% decline from fiscal 2022.
- EVOLUS, INC. payments for software for fiscal 2022 was $1.32M, a 128.94% increase from fiscal 2021.
| Period end | Payments for Software 3 month | Payments for Software 6 month | Payments for Software 9 month | Payments for Software 12 month |
|---|---|---|---|---|
| 2026-06-30 | $450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.73M 10-Q · filed 2026-08-05 | $2.41M derived: sum of 3 quarters · filed 2026-08-05 | $3.62M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.28M 10-Q · filed 2026-05-04 | $1.96M derived: sum of 2 quarters · filed 2026-05-04 | $3.17M derived: sum of 3 quarters · filed 2026-05-04 | $4.75M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.89M derived: sum of 2 quarters · filed 2026-03-03 | $3.47M derived: sum of 3 quarters · filed 2026-08-05 | $5.01M 10-K · filed 2026-03-03 |
| 2025-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.78M derived: sum of 2 quarters · filed 2026-08-05 | $4.32M 10-Q · filed 2025-11-05 | $5.25M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.12M 10-Q · filed 2026-08-05 | $4.04M derived: sum of 3 quarters · filed 2026-08-05 | $5.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.54M 10-Q · filed 2026-05-04 | $2.47M derived: sum of 2 quarters · filed 2026-05-04 | $3.56M derived: sum of 3 quarters · filed 2026-05-04 | $4.35M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $924.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.02M derived: sum of 2 quarters · filed 2026-03-03 | $2.81M derived: sum of 3 quarters · filed 2026-03-03 | $3.35M 10-K · filed 2026-03-03 |
| 2024-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.89M derived: sum of 2 quarters · filed 2025-11-05 | $2.43M 10-Q · filed 2025-11-05 | $2.58M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $789.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.33M 10-Q · filed 2025-08-05 | $1.48M derived: sum of 3 quarters · filed 2026-03-03 | $1.99M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $541.00K 10-Q · filed 2025-05-07 | $693.00K derived: sum of 2 quarters · filed 2026-03-03 | $1.20M derived: sum of 3 quarters · filed 2026-03-03 | $1.41M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $662.00K derived: sum of 2 quarters · filed 2026-03-03 | $870.00K derived: sum of 3 quarters · filed 2026-03-03 | $1.15M 10-K · filed 2026-03-03 |
| 2023-09-30 | $510.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $718.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.00M 10-Q · filed 2024-11-06 | $1.53M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $208.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $492.00K 10-Q · filed 2024-07-31 | $1.02M derived: sum of 3 quarters · filed 2025-03-04 | $1.41M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $284.00K 10-Q · filed 2024-05-07 | $809.00K derived: sum of 2 quarters · filed 2025-03-04 | $1.20M derived: sum of 3 quarters · filed 2025-03-04 | $1.36M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $915.00K derived: sum of 2 quarters · filed 2025-03-04 | $1.07M derived: sum of 3 quarters · filed 2025-03-04 | $1.32M 10-K · filed 2025-03-04 |
| 2022-09-30 | $390.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $547.00K derived: sum of 2 quarters · filed 2023-11-07 | $796.00K 10-Q · filed 2023-11-07 | $793.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $406.00K 10-Q · filed 2023-08-02 | $403.00K derived: sum of 3 quarters · filed 2023-08-02 | $382.00K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $249.00K 10-Q · filed 2023-05-09 | $246.00K derived: sum of 2 quarters · filed 2023-05-09 | $225.00K derived: sum of 3 quarters · filed 2023-05-09 | $611.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$24.00K derived: sum of 2 quarters · filed 2023-03-08 | $362.00K derived: sum of 3 quarters · filed 2023-03-08 | $577.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $365.00K derived: sum of 2 quarters · filed 2022-11-08 | $580.00K 10-Q · filed 2022-11-08 | $862.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $601.00K 10-Q · filed 2022-08-02 | $883.00K derived: sum of 3 quarters · filed 2022-08-02 | $1.46M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $215.00K 10-Q · filed 2022-05-10 | $497.00K derived: sum of 2 quarters · filed 2022-05-10 | $1.07M derived: sum of 3 quarters · filed 2022-05-10 | $1.60M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $860.00K derived: sum of 2 quarters · filed 2022-03-03 | $1.39M derived: sum of 3 quarters · filed 2022-03-03 | $2.32M 10-K · filed 2022-03-03 |
| 2020-09-30 | $578.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $1.11M derived: sum of 2 quarters · filed 2021-11-02 | $2.04M 10-Q · filed 2021-11-02 | $3.18M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $528.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.46M 10-Q · filed 2021-08-04 | $2.60M derived: sum of 3 quarters · filed 2021-08-04 | $3.24M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $935.00K 10-Q · filed 2021-05-12 | $2.08M derived: sum of 2 quarters · filed 2021-05-12 | $2.72M derived: sum of 3 quarters · filed 2021-05-12 | $4.33M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $1.78M derived: sum of 2 quarters · filed 2021-03-25 | $3.40M derived: sum of 3 quarters · filed 2021-03-25 | $4.22M 10-K · filed 2021-03-25 |
| 2019-09-30 | $639.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $2.26M derived: sum of 2 quarters · filed 2020-10-29 | $3.08M 10-Q · filed 2020-10-29 | $3.08M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.44M 10-Q · filed 2020-08-10 | $2.44M derived: sum of 3 quarters · filed 2020-08-10 | $2.44M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $823.00K 10-Q · filed 2020-05-11 | $823.00K derived: sum of 2 quarters · filed 2020-05-11 | $823.00K derived: sum of 3 quarters · filed 2020-05-11 | $823.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |